To see the Comparative effect of Kulattha Guda with or without virechana (purgation )in the management of Bronchial Asthma (tamaka shwasa)

A Randomized Comparative Clinical Trial To Evaluate The Efficacy Of Kulattha Guda With Or Without Virecahna Karma In The Management Of Tamaka Shwasa(Bronchial Asthma )

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019489

Enrollment

Registered

2019-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Kulattha Guda With Virechana: 15 Patients will be administered Kulattha Guda after Virechana Karma a)Virechana Yoga Abhyadi modak 2-3 tab(each tab 250mg) with anupana of Triphala Kw

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA- 1. Patients willing for trial and give consent. 2. Patients of age group 18 to 60 years of either sex. 3. Patients having signs and symptoms of Tamaka Shwasa (Bronchial asthma) as mentioned in Ayurvedic and Modern texts. 4. Patients fit for Virechana Karma.

Exclusion criteria

Exclusion criteria: 1. Patients not willing for trial. 2. Age below 18 and above 60years of either sex. 3. Patients suffering from Pulmonary Tuberculosis, Cardiac Asthma, Anaemia, Bronchus/Bronchogenic carcinoma, Chronic obstructive pulmonary disease, Pleural effusion. 4. Status asthmaticus. 5. Patients with rectal or vaginal prolapse. 6. Pregnant and lactating women. 7. Pateints suffering from serious systemic disorders like renal diseases, heart diseases, malignant hypertention, Diabetes Mellitus. Patients who are unfit for Virechana Karma.

Design outcomes

Primary

Measure	Time frame
changes in following parameters : 1.Shwasakrucchata (dyspnoea) 2.Kasa (cough) 3.Pratishyaya (chronic rhinitis) 4.Bhasankrucchata (difficulty in speech) 5.Nidralpata (inadequate sleep) Ghurghuraka (audible sounds) Timepoint: 4 weeks	—

Secondary

Measure	Time frame
changes in objective parameters 1. Spirometry. I. PEFR II. FEV1 % 2. Laboratory and Radiological Investigations- Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDrBabita Meena

National Institute Of Ayurveda

drajaysahu@gmail.com9950708106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026